Lipocine Inc.
LPCN
$3.10
$0.082.65%
NASDAQ
| 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | |
|---|---|---|---|---|---|
| Net Income | 28.12% | -153.08% | 178.09% | 66.64% | 13.53% |
| Total Depreciation and Amortization | 89.41% | 83.53% | 95.00% | 10.39% | 4.94% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 420.83% | 116.95% | 89.61% | -106.69% | 91.78% |
| Change in Net Operating Assets | -52.33% | 87.23% | -115.35% | -139.52% | 64.48% |
| Cash from Operations | 24.49% | -181.80% | 184.16% | -8.71% | 24.53% |
| Capital Expenditure | -- | -- | -8.70% | -- | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -5.31% | 78.43% | -71.81% | -11.30% | 33.48% |
| Cash from Investing | -5.31% | 78.43% | -72.09% | -17.74% | 33.48% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | -63.88% | -- | -- | -100.00% | -- |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | 255.77% |
| Cash from Financing | -65.23% | -- | 100.00% | -100.00% | 4,280.77% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 8.79% | -68.68% | 252.31% | -92.19% | 906.92% |